2013 Gastrointestinal Oncology Conference Review |
2013 Gastrointestinal Oncology Conference October 17-19, 2013 - Arlington, VA Please click on abstract title to review abstract PDF file (opens in a new window). |
Esophageal/Gastric Cancer |
DUODENOJEJUNAL ANGLE MALIGNANCY: A REAPPRAISAL Somprakas Basu, Vijay Kumar Shukla |
LOW GRADE PRIMARY DIGESTIVE LYMPHOMAS: ANATOMOCLINICAL STUDY AND THERAPEUTIC RESULTS: ABOUT 47 CASES Brik.S, Hochlef.M, Boudagga.MZ, Mejri.N, Ezzaairi.F, Chabchoub.I, Gharbi.O, Ben Fatma.L, Ben Ahmed.S |
PEDIATRIC GASTROINTESTINAL TUMORS AND THEIR RADIOLOGIC APPEARANCE. Aman Chauhan, Kenneth Ward |
MECHANISMS INVOLVED IN THE DEVELOPMENT OF DUODENAL STUMP FISTULA/LEAKAGE Ding Lian-An, Niu Dong-Guang, Shao Chang-Chun, Cheng Hong-Gang, Sun Zhen-Qing Zhang Jian-Li |
THE CLINICAL APPLICATION OF 18F-FDG PET/CT IN THE DIAGNOSTIC OF GASTRIC CANCERS Liu Lu-guang, DING Lian-an |
STUDY ON RELATIONSHIP BETWEEN CIRCULATING MYOSTATIN AND GASTRIC CARCINOMA ASSOCIATED CACHEXIA CAO Shu-cheng*, DING Lian-an, NIU Dong-guang Wang Lin, YAO Ru-yong |
THE STUDY ON APPLICATION OF ENTERAL NUTRITION TO POSTOPERATIVE PATIENTS WITH GASTRIC CANCER Hou Qing-Meng, Ding Lian-An |
SAFETY AND SHORT PROCEDURE TIME USING INSERTION OF SELF EXPANDING METAL STENT IN MALIGNANT ESOPHAGEAL STRICTURE WITHOUT FLUOROSCOPY J. B. Hong*, C. W. Choi, D. H. Kang, H. W. Kim, S. B. Park, B. J. Song, S. J. Kim |
EFFICACY OF ENDOSCOPIC ULTRASONOGRAPHY COMPARED TO CONVENTIONAL ENDOSCOPY FOR TUMOR INVASION DEPTH IN EARLY GASTRIC CANCER SJ Kim, DH Kang, CW Choi, HW Kim, SB Park, BJ Song |
RADIOTHERAPY OF CARCINOMA OESOPHAGUS: AVOIDING OVERLAPPING INVESTIGATIONS AND TAILORING DELIVERY TECHNIQUE IMPROVES PATIENTS’ COMPLIANCE AND REDUCES TREATMENT COST Ramaiah Vinay Kumar, M.D., Dinesh M Gangaiah, M.S., Dr.Madhu S D, M.D., Pramod K P R, M.D. |
INCIDENCE OF RARE HISTOPATHOLOGICAL VARIANTS OF GASTRIC TUMORS - A UNIVERSITY HOSPITAL EXPERIENCE R.Niranjan(Presenting author) senthil anand,sankar narayanan,anisha ashok,Babu elangovan, J.Thanka ( Prof; Dept; histopathology) Sreenivasan Karuparthi,(Prof: Dept of GI surgery ) Sankar Subramanian.(Prof and HOD Dept of GI surgery) Tnagar, Chennai |
ESOPHAGEAL CANCER SURVIVAL IN U.S. ADULTS FROM 1973 TO 2009: A SEER DATABASE ANALYSIS OF TEMPORAL TRENDS, INDEPENDENT PREDICTORS OF MORTALITY AND A NOVEL PROGNOSTIC SCORE Basile Njei, MD, MPH; John W. Birk, MD, FACG |
PATHOLOGICAL COMPLETE RESPONSE AFTER CHEMOTHERAPY WITH S-1, CISPLATIN, AND TRASTUZUMAB IN GASTRIC CANCER: A CASE REPORT. Yusuke Shimodaira, Akihiro Suzuki, Hisashi Onodera |
SURVIVAL IMPACT OF ESOPHAGECTOMY AFTER CHEMORADIATION FOR ADENOCARCINOMA OF THE ESOPHAGUS Ravi Shridhar MD-PhD, Jessica Freilich MD, Sarah E. Hoffe MD, Khaldoun Almhanna MD, William J Fulp MS, MPH, Binglin Yue, Richard C. Karl MD, FACS, and Kenneth Meredith MD, FACS |
A CASE REPORT OF AN EXTRAİNTESTİNAL GIST PRESENTİNG AS A GİANT ABDOMİNOPELVİC TUMOR Prof. Dr. Cavit ÇÖL |
INFLAMMATORY FIBROID POLYP Chauhan A and Joshi V |
Pancreatic Cancer |
TARGETED MOLECULAR ROBOTIC NANOSURGERY ERADICATES PANCREATIC CANCER STEM CELLS WITH RADIOFREQUENCY DIELECTRIC HEATING (RFDH)AND SILVER-IMMUNONANOBOTS. John N Giannios |
A PHASE 2, RANDOMIZED TRIAL OF GVAX PANCREAS AND CRS-207 IMMUNOTHERAPY VERSUS GVAX ALONE IN PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA: ONGOING SAFETY AND EFFICACY RESULTS Dung T. Le, Andrea Wang-Gillam, Vincent Picozzi, Tim Greten, Todd Crocenzi, Gregory Springett, Michael Morse, Herbert Zeh, Deidre Cohen, Robert Fine, Beth Onners, Jennifer Uram, Daniel Laheru, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas Dubensky, Jr., Dirk Brockstedt, Elizabeth M. Jaffee |
METASTATIC NON- SMALL CELL LUNG CANCER TO THE LIVER AND PANCREAS Laurie Matt, MD, MPH; Rajesh Sehgal, MD |
POST OPERATIVE COMPLICATION AFTER PANCREATICODUODENECTOMY, A COMPARATIVE STUDY WITH INTERNATIONAL STANDARDS Dr Shanavas K, Dr Prathapan Valiya Kambrath |
NASOGASTRIC DECOMPRESSION IN GASTRECTOMIES- IS IT USEFUL? A RCT. Dr. Preethi S Shetty, MS, Senior Resident, Dr. Prathapan V.K., MS, MCh, Professor & HOD |
RISK FACTORS OF MALIGNANCY IN TROPICAL CHRONIC CALCIFIC PANCREATITIS – RETROSPECTIVE STUDY. Dr. Preethi S Shetty, MS, Senior Resident, Dr. Prathapan V.K., MS, MCh, Professor & HOD |
Advanced Colon Cancer |
THE ROLE OF SHORT CHAIN FATTY ACIDS IN ANGIOGENESIS A. Hamad*, RM Day, A.Forbes, A.Burns |
A VELOUR POST HOC SUBSET ANALYSIS: PROGNOSTIC GROUPS AND TREATMENT OUTCOMES IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED WITH AFLIBERCEPT AND FOLFIRI Ian Chau, Florence Joulain, Sheikh Usman Iqbal, John Bridgewater |
AFLIBERCEPT INHIBITS TUMOR GROWTH MORE EFFECTIVELY THAN BEVACIZUMAB IN PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF COLORECTAL CANCER M. Chiron, R.G. Bagley, J.R. Pollard, C. Henry, P.K. Mankoo, L. Vincent, C. Geslin, Z. Amalou, N. Baltes, D.A. Bergstrom |
BUDGETARY IMPACT OF THE ADDITION OF ZIV-AFLIBERCEPT TO A HEALTH PLAN FORMULARY AS A POST-OXALIPLATIN PROGRESSION BIOLOGIC OPTION FOR TREATING PATIENTS WITH METASTATIC COLORECTAL CANCER Shelby L. Corman, Mei Xue, Dan Hennessy, Susan Pacconi, Edward Drea, Stephen F. Thompson, Xin Gao |
TIME COURSE OF ADVERSE EVENTS IN THE VELOUR TRIAL David R. Ferry, Paul Ruff, Radek Lakomy, Jana Prausova, Guy A. van Hazel, Vladimir M. Moisyenko, Raghu Vishwanath, Emmanuelle Dochy, Eric Van Cutsem, Teresa Macarulla |
IS ENDOSCOPIC COLORECTAL STENTING AS A BRIDGE TO SURGERY REALLY USEFUL FOR MALIGNANT COLONIC OBSTRUCTION? SJ Kim, HW Kim, DH Kang, CW Choi, SB Park, BJ Song |
OBSERVED BENEFIT OF AFLIBERCEPT IN MCRC PATIENTS ≥65 YEARS: RESULTS OF A PRESPECIFIED AGE-BASED ANALYSIS OF THE VELOUR STUDY Paul Ruff, David R. Ferry, Demetris Papamichael, Radek Lakomy, Jana Prausova, Guy A. van Hazel, Vladimir M. Moisyenko, Karen Soussan-Lazard, Emmanuelle Dochy, Eric Van Cutsem, Teresa Macarulla |
AFLIBERCEPT/FOLFIRI VS PLACEBO/FOLFIRI IN METASTATIC COLORECTAL CANCER: POST-HOC ANALYSIS OF SURVIVAL BY PRIOR BEVACIZUMAB USE SUBSEQUENT TO EXCLUSION OF PATIENTS WHO HAD RECURRENCE DURING OR WITHIN 6 MONTHS OF COMPLETING ADJUVANT OXALIPLATIN-BASED THERAPY Eric Van Cutsem, David Raymond Ferry, Radek Lakomy, Pankaj Bhargava, Jana Prausova, Guy Van Hazel, Vladimir Moiseyenko, Joseph McKendrick, Emmanuelle Boelle, Teresa Macarulla |
CLINICAL ASPECTS OF COLORECTAL CANCER PATIENTS AGE 80 AND OVER Wong L; Wortman K; Song J; Ashley P; Wajima T |
Hot Topics in Gastrointestinal Oncology |
A PILOT STUDY INVESTIGATING THE ABILITY OF ADVANCED BIPOLAR RF DEVICE TO INDUCE BLOOD VESSEL HAEMOSTASIS BY ACTIVATION OF THE COAGULATION PATHWAY Malaz Elsaddig BSc |
Localized Adjuvant CRC |
CONSERVATIVE APPROACH AFTER RADIOCHEMOTHERAPY IN RECTAL CANCER: A META-ANALYSIS. Francesco Fiorica, Antonio Stefanelli, Marina Marzola , Marcello Daniele , Simona Ascanelli , Carlo Feo, Gabriele Anania, Resta Giuseppe, Fabrizio Di Benedetto, Fabrizio D’Acapito, Giorgio Verdecchia |
NO MAJOR SURGERY APPROACH IN RECTAL CANCER WITH MAJOR REGRESSION: A PHASE II STUDY PROTOTCOL (IRIS STUDY). Francesco Fiorica , Antonio Stefanelli, Marina Marzola , Marcello Daniele, Simona Ascanelli, Carlo Feo, Gabriele Anania, Resta Giuseppe, Fabrizio Di Benedetto, Fabrizio D’Acapito, Giorgio Verdecchia |
SAFETY AND EFFICACY OF LAPAROSCOPIC COLECTOMY ON ELDERLY COLON CANCER PATIENTS: AGE SPECIFIC OUTCOMES OF LAPAROSCOPIC COLECTOMY Naruhiko Ikoma MD, Osamu Itano MD, PhD, Laura Kreiner MD, Shinichi Fukuhara MD, Yuko Kitagawa MD, PhD, FACS |
HOW MUCH CAN WE RELY ON PRE-OPERATIVE CT STAGING IN COLORECTAL CANCER? Dimitris-Christos Zachariades, Siegfried Wagner |
Neuroendocrine Tumors (NET) |
ABOVE THE STANDARD DOSE OF OCTREOTIDE-LAR IN PATIENTS WITH NEUROENDOCRINE TUMORS (NET) Jamie Goldman, MD; Matthew H. Kulke, MD; Jonathan R. Strosberg, MD; Lynn Huynh, MPH, MBA, DrPH; Mei Sheng Duh, MPH, ScD; Vaibhav Sahai, MD, MS; Alfred W. Rademaker, PhD; Al B. Benson, MD |
Hepatobiliary Cancer |
PROGNOSIS OF PATIENTS WITH FIBROLAMELLAR HEPATOCELLULAR CARCINOMA VERSUS CONVENTIONAL HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS Basile Njei, MD, MPH |
RECURRENT DISEASE AFTER LIVING DONOR LIVER TRANSPLANTATION: RISK FACTORS, MANAGEMENT AND OUTCOME. Emad Hamdy Salem, Tarek Ibrahim, Amr Helmy, Hesham Abdeldayem, Maher Osman, Ibrahim Abdelkader |
SYSTEMIC THERAPY FOR ADVANCED STAGE HEPATOCELLULAR CARCINOMA – BEYOND SORAFENIB Steven Alberts, MD MPH |
LOCOREGIONAL/LIVER DIRECTED THERAPIES Karen T. Brown, MD, FSIR |
HER2 MAY NOT BE AN INTERESTING TARGET IN BILIARY CANCERS: RESULTS OF AN EARLY PHASE II STUDY WITH LAPATINIB Joshua Peck, Lai Wei, Mark Zalupski, Bert O'Neil, Miguel Villalona Calero, Tanios Bekaii-Saab |
ADJUVANT THERAPY FOR BILIARY CANCER Jennifer J. Knox, MD, MSc, FRCPC |
©2022 International Society of Gastrointestinal Oncology | info@isgio.org |